全文获取类型
收费全文 | 21406篇 |
免费 | 2042篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 237篇 |
儿科学 | 762篇 |
妇产科学 | 571篇 |
基础医学 | 2929篇 |
口腔科学 | 430篇 |
临床医学 | 3162篇 |
内科学 | 4046篇 |
皮肤病学 | 250篇 |
神经病学 | 2090篇 |
特种医学 | 467篇 |
外国民族医学 | 5篇 |
外科学 | 2116篇 |
综合类 | 331篇 |
一般理论 | 28篇 |
预防医学 | 3017篇 |
眼科学 | 282篇 |
药学 | 1299篇 |
中国医学 | 12篇 |
肿瘤学 | 1457篇 |
出版年
2023年 | 194篇 |
2022年 | 263篇 |
2021年 | 479篇 |
2020年 | 373篇 |
2019年 | 560篇 |
2018年 | 578篇 |
2017年 | 478篇 |
2016年 | 446篇 |
2015年 | 532篇 |
2014年 | 706篇 |
2013年 | 995篇 |
2012年 | 1419篇 |
2011年 | 1470篇 |
2010年 | 775篇 |
2009年 | 718篇 |
2008年 | 1170篇 |
2007年 | 1246篇 |
2006年 | 1168篇 |
2005年 | 1070篇 |
2004年 | 1001篇 |
2003年 | 922篇 |
2002年 | 891篇 |
2001年 | 442篇 |
2000年 | 372篇 |
1999年 | 316篇 |
1998年 | 199篇 |
1997年 | 175篇 |
1996年 | 156篇 |
1995年 | 166篇 |
1994年 | 146篇 |
1993年 | 118篇 |
1992年 | 245篇 |
1991年 | 258篇 |
1990年 | 237篇 |
1989年 | 220篇 |
1988年 | 200篇 |
1987年 | 200篇 |
1986年 | 214篇 |
1985年 | 204篇 |
1984年 | 160篇 |
1983年 | 141篇 |
1982年 | 104篇 |
1981年 | 101篇 |
1980年 | 93篇 |
1979年 | 147篇 |
1978年 | 129篇 |
1977年 | 106篇 |
1976年 | 106篇 |
1974年 | 97篇 |
1973年 | 102篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
Ana L Hermogenes Michael Richardson Arinos Magalhaes Armando Yarleque Edith Rodriguez Eladio F Sanchez 《Toxicon》2006,47(4):490-494
Lachesis venom plasminogen activator (LV-PA) is a 33-kDa serine proteinase isolated from bushmaster (Lachesis muta muta) snake venom, which activates the fibrinolytic system in vitro. This study has examined the effect of the plasma proteinase inhibitor alpha2-macroglobulin (alpha2-M) towards LV-PA and compares it with the effect on tissue type plasminogen activator (t-PA). The proteolytic activity of LV-PA alone or previously incubated with human plasminogen (Plg) on the large molecular mass protein substrates, dimethylcasein (DMC) and fibrinogen (Fg) was completely inhibited by human alpha2-M. However, the synthetic peptides Tos-Gly-Pro-Lys-pNA and H-D-Pro-Phe-Arg-pNA (S-2302) were hydrolyzed with almost no reduction in rate. At pH 7.4 and 37 degrees C the proteinase (0.15 microM over 15 min) interacted with alpha2-M, and each mole of alpha2-M bound 2 mol of enzyme. Sodium dodecyl sulfate gel electrophoresis of reduced samples showed that the interaction of alpha2-M with either LV-PA or t-PA preincubated with Plg resulted in the formation of approximately 90 kDa fragments and high molecular mass complexes (Mr 180 kDa), generated by the incubation mixture (LV-PA or t-PA) and Plg. The data suggest that LV-PA is a direct-type PA and its fibrinolytic effect can be reduced by alpha2-M in vivo. 相似文献
24.
Jens O L J?rgensen Louise M?ller Morten Krag Nils Billestrup Jens S Christiansen 《Endocrinology & Metabolism Clinics of North America》2007,36(1):75-87
This article focuses on in vivo data from tests performed in normal subjects and in patients who had abnormal growth hormone (GH) status. Experimental data in human subjects demonstrate that GH acutely inhibits glucose disposal in skeletal muscle. At the same time GH stimulates the turnover and oxidation of free fatty acid (FFA), and experimental evidence suggests a causal link between elevated FFA levels and insulin resistance in skeletal muscle. Observational data in GH-deficient adults do not indicate that GH replacement is associated with significant impairment of glucose tolerance, but it is recommended that overdosing be avoided and glycemic control be monitored. 相似文献
25.
Penny Dash Chris Llewellyn Ben Richardson 《医院领导决策参考》2009,(20):29-32
医疗改革是一个世界性难题,各国在医疗改革中都会遇到各自相关的问题。改革艰巨,但并不是不可能完成,本文作者认为,通过关注以分区的方式提供医疗服务可以让医疗改革取得实效。本文从划定分区边界的方式出发,介绍了制定分区医疗战略的五个步骤,并讨论了各医疗系统成功实施各自战略所需采取的措施,这也可以为我国正在推行的医疗改革提供一定的借鉴和参考。 相似文献
26.
Charlotte J. Harden Bernard M. Corfe J. Craig Richardson Peter W. Dettmar Jenny R. Paxman 《Nutrition Research》2009
This cross-sectional analysis evaluated the effect of age and body mass index (BMI) on Three-Factor Eating Questionnaire scores in males. Subjects (n = 60) were recruited according to BMI status. Each completed the 51-item Three-Factor Eating Questionnaire. The group was split at the median age to produce a “younger” and “older” group for statistical analysis. A 2-way between-groups analysis of variance revealed a significant main effect of BMI on disinhibition (P = .003) and hunger (P = .041) with higher levels found in overweight males compared to healthy-weight counterparts. A significant main effect of age on hunger (P = .046) demonstrated older males were less susceptible to hunger than younger males. These insights provide a better understanding of eating behavior across the male life cycle and may assist health professionals to better guide men in weight management in the light of rising overweight/obesity. 相似文献
27.
Canadian Journal of Anesthesia/Journal canadien d'anesthésie - 相似文献
28.
Chymotrypsin treatment of the enterotoxin from Clostridium perfringens results in the loss of 36 amino acids from the N-terminus and 3 amino acids from the C-terminus. This processing results in a 3.2 fold increase in activity on Vero cells, which is close to what had been found for trypsin treatment following the loss of 25 amino acids from the N-terminus. 相似文献
29.
Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer. 总被引:3,自引:0,他引:3
Amit Shah William A Swain Donna Richardson John Edwards Duncan J Stewart Catherine M Richardson Daniel E B Swinson Dipika Patel J Louise Jones Kenneth J O'Byrne 《Clinical cancer research》2005,11(8):2930-2936
Akt, a Serine/Threonine protein kinase, mediates growth factor-associated cell survival. Constitutive activation of Akt (phosphorylated Akt, P-Akt) has been observed in several human cancers, including lung cancer and may be associated with poor prognosis and chemotherapy and radiotherapy resistance. The clinical relevance of P-Akt in non-small cell lung cancer (NSCLC) is not well described. In the present study, we examined 82 surgically resected snap-frozen and paraffin-embedded stage I to IIIA NSCLC samples for P-Akt and Akt by Western blotting and for P-Akt by immunohistochemistry. P-Akt protein levels above the median, measured using reproducible semiquantitative band densitometry, correlated with a favorable outcome (P = 0.007). Multivariate analysis identified P-Akt as a significant independent favorable prognostic factor (P = 0.004). Although associated with a favorable prognosis, high P-Akt levels correlated with high tumor grade (P = 0.02). Adenocarcinomas were associated with low P-Akt levels (P = 0.039). Akt was not associated with either outcome or clinicopathologic variables.Cytoplasmic (CP-Akt) and nuclear (NP-Akt) P-Akt tumor cell staining was detected in 96% and 42% of cases, respectively. Both CP-Akt and NP-Akt correlated with well-differentiated tumors (P = 0.008 and 0.017, respectively). NP-Akt also correlated with nodal metastases (P = 0.022) and squamous histology (P = 0.037).These results suggest P-Akt expression is a favorable prognostic factor in NSCLC. Immunolocalization of P-Akt, however, may be relevant as NP-Akt was associated with nodal metastases, a known poor prognostic feature in this disease. P-Akt may be a potential novel therapeutic target for the management of NSCLC. 相似文献
30.
J N Nankani M Northfield Y M Beran P D Richardson 《Current medical research and opinion》1990,12(3):198-206
An open, multi-centre, general practice study was carried out in 1661 asthmatic patients to assess the efficacy, in terms of symptom relief and changes in lifestyle, of budesonide and to record objective lung function changes and any adverse events. After a 1-week run-in period on any pre-trial anti-asthma medication, patients received either 200 micrograms or 400 micrograms budesonide twice daily by metered dose inhaler for 4 weeks. Peak expiratory flow rate (PEFR) was measured by the doctor on entry, after the run-in, and at the end of the study and patients were asked to complete diary cards on a daily basis to record compliance, bronchodilator usage and the severity of cough, wheeze and sleep disturbance, and weekly to record 5 lifestyle assessments, e.g. physical activity. Analysis of data from the clinic visits and 1375 completed diary cards showed that PEFR increased significantly from 321 +/- 3 l/min at the end of the run-in to 368 +/- 3 l/min at the end of the trial; 77% of patients had an improved PEFR. Bronchodilator use decreased significantly from 4.2 +/- 0.1 times/day during the run-in period to 3.0 +/- 0.1 times/day at the end of the study; 65% of patients used less bronchodilator. Significant improvements were recorded in all the symptoms and lifestyle indices monitored; 76% of patients improved in at least 5 of the 11 assessments. Treatment-emergent adverse events occurred in 103 (6%) of patients: none was classified as serious or unexpected. No sub-group of patients was identified in which the results were at variance from the full sample. It is concluded that budesonide improves patients' lifestyle and ability to carry out normal activities, as well as improving PEFR and reducing bronchodilator use, in mild to moderately severe asthmatics treated in general practice. 相似文献